- STAT+: Under a new leader, the FDA’s biologics center moves to steady itself after stormy chapterAfter his predecessor's turbulent tenure, Karim Mikhail is working to restore staff morale and revisit controversial rejections.STAT · 10d ago↗ source
- STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expectA new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has taken the world by storm.STAT · 10d ago↗ source
- Opinion: Why we still don’t know what foods are the source of the cyclospora outbreak“You cannot thin a system, defer the tools that would speed it up, and then wonder why the public is left guessing,” writes epidemiologist Katrine Wallace.